微信小陈
微信小章| 产品名称： | Cryptococcus neoformans (Sanfelice) Vuillemin |
|---|---|
| 商品货号： | TS156614 |
| Deposited As： | Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph |
| Strain Designations： | 305 (cap 64) |
| Alternate State： | Filobasidiella neoformans Kwon-Chung |
| Application： | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Comments： | Acapsular mutant |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | ES Jacobson |
| References： | Fromtling RA, et al. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia 79: 23-29, 1982. PubMed: 6750405 Jacobson ES, Payne WR. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J. Bacteriol. 152: 932-934, 1982. PubMed: 6752126 Still CN, Jacobson ES. Recombinational mapping of capsule mutations in Cryptococcus neoformans. J. Bacteriol. 156: 460-462, 1983. PubMed: 6352689 Jacobson ES, et al. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J. Bacteriol. 150: 1292-1296, 1982. PubMed: 7042689 |